Logo image of PVG

Pretium Resources Inc (PVG) Stock Fundamental Analysis

NYSE:PVG - New York Stock Exchange, Inc. - KYG7613T1031 - Common Stock - Currency: USD

15.05  -0.2 (-1.31%)

After market: 15.1 +0.05 (+0.33%)

Fundamental Rating

2

Overall PVG gets a fundamental rating of 2 out of 10. We evaluated PVG against 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of PVG have multiple concerns. PVG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year PVG was profitable.
PVG Yearly Net Income VS EBIT VS OCF VS FCFPVG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA -2.32%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PVG Yearly ROA, ROE, ROICPVG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 5 -5 10 15

1.3 Margins

Industry RankSector Rank
OM 31.65%
PM (TTM) -4.7%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PVG Yearly Profit, Operating, Gross MarginsPVG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 10 20 30

3

2. Health

2.1 Basic Checks

PVG has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, PVG has an improved debt to assets ratio.
PVG Yearly Shares OutstandingPVG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M 150M
PVG Yearly Total Debt VS Total AssetsPVG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 500M 1B 1.5B

2.2 Solvency

PVG has an Altman-Z score of 4.76. This indicates that PVG is financially healthy and has little risk of bankruptcy at the moment.
PVG has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 4.76
ROIC/WACCN/A
WACCN/A
PVG Yearly LT Debt VS Equity VS FCFPVG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 200M -200M 400M 600M 800M

2.3 Liquidity

PVG has a Current Ratio of 1.28. This is a normal value and indicates that PVG is financially healthy and should not expect problems in meeting its short term obligations.
PVG has a Quick Ratio of 1.13. This is a normal value and indicates that PVG is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.13
PVG Yearly Current Assets VS Current LiabilitesPVG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for PVG have decreased strongly by -16.47% in the last year.
PVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 121.20% yearly.
Looking at the last year, PVG shows a small growth in Revenue. The Revenue has grown by 4.72% in the last year.
PVG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.42% yearly.
EPS 1Y (TTM)-16.47%
EPS 3Y121.2%
EPS 5YN/A
EPS Q2Q%-51.85%
Revenue 1Y (TTM)4.72%
Revenue growth 3Y51.42%
Revenue growth 5YN/A
Sales Q2Q%-5.21%

3.2 Future

The Earnings Per Share is expected to decrease by -3.85% on average over the next years.
PVG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.24% yearly.
EPS Next Y-38.93%
EPS Next 2Y-7.77%
EPS Next 3Y-11.8%
EPS Next 5Y-3.85%
Revenue Next Year0.02%
Revenue Next 2Y5.24%
Revenue Next 3Y1.08%
Revenue Next 5Y1.24%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PVG Yearly Revenue VS EstimatesPVG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
PVG Yearly EPS VS EstimatesPVG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4 0.6 0.8

1

4. Valuation

4.1 Price/Earnings Ratio

PVG is valuated rather expensively with a Price/Earnings ratio of 21.20.
PVG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 18.62, PVG is valued on the expensive side.
The average S&P500 Price/Forward Earnings ratio is at 21.70. PVG is around the same levels.
Industry RankSector Rank
PE 21.2
Fwd PE 18.62
PVG Price Earnings VS Forward Price EarningsPVG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.51
PVG Per share dataPVG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

A cheap valuation may be justified as PVG's earnings are expected to decrease with -11.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.77%
EPS Next 3Y-11.8%

0

5. Dividend

5.1 Amount

PVG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Pretium Resources Inc

NYSE:PVG (3/8/2022, 8:22:34 PM)

After market: 15.1 +0.05 (+0.33%)

15.05

-0.2 (-1.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)03-04 2022-03-04/amc
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.83B
Analysts50
Price Target14.47 (-3.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.2
Fwd PE 18.62
P/S 4.63
P/FCF N/A
P/OCF N/A
P/B 3.33
P/tB N/A
EV/EBITDA 9.51
EPS(TTM)0.71
EY4.72%
EPS(NY)0.81
Fwd EY5.37%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.25
BVpS4.52
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.32%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 31.65%
PM (TTM) -4.7%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 1.13
Altman-Z 4.76
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.47%
EPS 3Y121.2%
EPS 5YN/A
EPS Q2Q%-51.85%
EPS Next Y-38.93%
EPS Next 2Y-7.77%
EPS Next 3Y-11.8%
EPS Next 5Y-3.85%
Revenue 1Y (TTM)4.72%
Revenue growth 3Y51.42%
Revenue growth 5YN/A
Sales Q2Q%-5.21%
Revenue Next Year0.02%
Revenue Next 2Y5.24%
Revenue Next 3Y1.08%
Revenue Next 5Y1.24%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A